Step 1 topics → Psychiatry → Binge Eating Disorder

Binge Eating Disorder

USMLE Step 1 trap: Distinguishes binge eating disorder from bulimia by frequency alone, missing that absence of compensatory behaviors is the defining criterion. The defining distinction is that binge eating disorder has NO compensatory behaviors (no purging, fasting, or excessive exercise), whereas bulimia nervosa requires recurrent compensatory behaviors.

Binge eating disorder (BED) is the most common eating disorder in the US, characterized by recurrent episodes of eating large amounts of food with a sense of loss of control — but critically, without any compensatory behaviors afterward. That last part is the whole ballgame on USMLE Step 1. Students who know bulimia nervosa well often slide into BED questions and miss the key distinguishing feature, focusing on episode frequency rather than what happens after the binge. The exam exploits this directly.

Step 1 tests BED in two main ways: diagnostic criteria (especially what distinguishes it from bulimia) and management (both psychotherapy and the one FDA-approved medication). Passage-based questions will describe a patient who binges, feels guilty and distressed, but does NOT purge, fast, or over-exercise — you need to recognize that pattern instantly. Application questions may give you a patient with obesity and recurrent binge episodes and ask what you'd prescribe, which requires knowing the pharmacology cold.

The tricky part is that BED and bulimia share the binge episode as a core feature, so students instinctively compare them by episode count or severity. USMLE Step 1 is testing whether you know the structural difference: bulimia requires compensatory behaviors; BED, by definition, does not. If you anchor on that, the diagnostic questions become straightforward. The management question is a pure recall gap — most students don't know lisdexamfetamine is FDA-approved for BED specifically.

From real student decks
62%have cards covering this topic
41%have mature cards

Common misconceptions

Common mistake
Wrong: Binge eating disorder and bulimia nervosa differ only in the frequency of binge episodes.
Right: The defining distinction is that binge eating disorder has NO compensatory behaviors (no purging, fasting, or excessive exercise), whereas bulimia nervosa requires recurrent compensatory behaviors.
Frequency of binge episodes is a shared feature between BED and bulimia nervosa, so using it as the distinguishing criterion will get you burned. The true structural difference is behavioral: bulimia nervosa requires recurrent compensatory behaviors (purging, fasting, laxatives, excessive exercise) to offset the binge, while BED has none of these. When you read a vignette, look for what the patient does AFTER eating — if the answer is 'nothing but guilt,' think BED, not bulimia.
Common mistake
Gap: Missing that lisdexamfetamine is the only FDA-approved medication for binge eating disorder
Lisdexamfetamine (Vyvanse) is the only FDA-approved pharmacologic agent for binge eating disorder; CBT is first-line psychotherapy.
Lisdexamfetamine (Vyvanse) was originally approved for ADHD, but it's also the sole FDA-approved medication for moderate-to-severe binge eating disorder — a fact USMLE Step 1 has directly tested. SSRIs are sometimes used off-label, and topiramate has evidence, but neither is FDA-approved for BED. If a question asks for the pharmacologic treatment of BED specifically, lisdexamfetamine is the answer; CBT remains first-line if they ask about overall management approach.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the DSM-5 criteria for binge eating disorder: binge episodes occurring at least once a week for 3 months, with marked distress, and — most importantly — the complete absence of recurrent compensatory behaviors like purging, fasting, or excessive exercise.
  2. Know first-line management: CBT (cognitive behavioral therapy) is the first-line psychotherapy, and lisdexamfetamine (Vyvanse) is the only FDA-approved pharmacologic agent for moderate-to-severe binge eating disorder.

Can you avoid these mistakes?

A 34-year-old woman reports eating very large amounts of food at least twice a week for the past 4 months, always feeling out of control during episodes. Afterward she feels ashamed but does not vomit, use laxatives, or increase her exercise. What is the diagnosis, and what single feature most clearly distinguishes it from bulimia nervosa?
A patient is diagnosed with moderate binge eating disorder. What is the first-line psychotherapy, and what is the only FDA-approved medication for this condition?
A question stem describes a patient with recurrent binge episodes and compensatory fasting between episodes. Does this patient have binge eating disorder or bulimia nervosa? What is the key criterion that decides this?
Two patients present to a psychiatry clinic: Patient A has recurrent binge episodes twice weekly for 4 months and afterward exercises for 2 hours and fasts the next day. Patient B has recurrent binge episodes twice weekly for 4 months and afterward feels shame and guilt but does nothing else. A medical student says both patients have binge eating disorder because their binge frequency is the same. What is wrong with this reasoning, and what is the correct diagnosis for each patient?

Related topics

Bulimia Nervosa Major Depressive Disorder (MDD) Persistent Depressive Disorder (Dysthymia) Bipolar I Disorder Bipolar II Disorder

See how your Anki deck covers this topic.

Upload your deck for a free audit →